B군 수막구균 감염병 예방접종백신 4CMenB접종 결과가 좋다고 한다.
The 4CMenB program was associated with continued positive effect against meningococcal group B disease in children in England, and protection after three doses of the vaccine was sustained for at least 2 years.
4CMenB uptake in England remained consistently high.